Sunitinib Pharmagen 25 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmagen 25 mg

pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sunitinib Pharmagen 12,5 mg Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sunitinib pharmagen 12,5 mg

pharmagen cz s.r.o., Česká republika - sunitinib - 44 - cytostatica

Sutent European Union - Slovak - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastické činidlá - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.

Odomzo European Union - Slovak - EMA (European Medicines Agency)

odomzo

sun pharmaceutical industries europe b.v. - sonifegib difosfát - karcinóm, bazálna bunka - antineoplastické činidlá - odomzo je indikovaný na liečbu dospelých pacientov s lokálne pokročilým bazocelulárny karcinóm (bcc), ktorí nie sú ochotná liečebný chirurgie alebo radiačnej terapie.

Gemcitabín SUN 10 mg/ml infúzny roztok Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

gemcitabín sun 10 mg/ml infúzny roztok

sun pharmaceutical industries europe b.v. , holandsko - gemcitabín - 44 - cytostatica